Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECZTRA 6: Tralokinumab Monotherapy in Adolescent Atopic Dermatitis
2017-005143-33Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tralokinumab in atopic dermatitis (AD), sponsored by LEO Pharma. Started Jun 2018; status: completed.
02
Drugs
tralokinumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2017-005143-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005143-33.